Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-17

FDA Approved: ATENOLOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Atenolol from Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atenolol (Atenolol)

Snippet

SUPPL AP for ATENOLOL (ATENOLOL)